12月31日，华康洁净盘中下跌2.02%，截至13:58，报36.80元/股，成交1.52亿元，换手率5.60%，总市值 39.66亿元。 分红方面，华康洁净A股上市后累计派现4002.14万元。近三年，累计派现2946.14万元。 机构持仓方面，截止2025年9月30日，华康洁净十大流通股东中，富国优化增强债券A/B（100035）位 居第六大流通股东，持股180.00万股，为新进股东。富国久利稳健配置混合型A（003877）位居第九大 流通股东，持股49.78万股，为新进股东。招商量化精选股票发起式A（001917）位居第十大流通股东， 持股47.00万股，为新进股东。安信医药健康股票A（010709）、诺安多策略混合A（320016）退出十大 流通股东之列。 责任编辑：小浪快报 资料显示，武汉华康世纪洁净科技股份有限公司位于湖北省武汉市东湖新技术开发区高新大道718号3 栋，成立日期2008年11月12日，上市日期2022年1月28日，公司主营业务涉及医疗净化系统研发、设 计、实施和运维,相关医疗设备和医疗耗材的销售。主营业务收入构成为：净化系统集成85.24%，医疗 耗材销售8.53%，医疗设备销售3 ...

12月25日，华康洁净涨5.12%，截至发稿，报44.97元/股，成交4.54亿元，换手率14.54%，总市值48.47 亿元。 招商量化精选股票发起式A（001917）基金经理为王平。 截至发稿，王平累计任职时间15年191天，现任基金资产总规模212.47亿元，任职期间最佳基金回报 271.58%， 任职期间最差基金回报-70.61%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 资料显示，武汉华康世纪洁净科技股份有限公司位于湖北省武汉市东湖新技术开发区高新大道718号3 栋，成立日期2008年11月12日，上市日期2022年1月28日，公司主营业务涉及医疗净化系统研发、设 计、实施和运维,相关医疗设备和医疗耗材的销售。主营业务收入构成为：净化系统集成85.24%，医疗 耗材销售8.53%，医疗设备销售3.74%，运维服务1.88%，其他(补充)0.61%。 从华康洁净十大流通股东角度 数据显示，招商基金旗下1只基金位居华康洁净十大流通股东。招商量化精选股票发起式 ...

Core Viewpoint - Huakang Clean experienced a decline of 3.26% in stock price on December 24, with a trading volume of 670 million yuan, indicating potential volatility in the stock market performance [1] Financing Summary - On December 24, Huakang Clean had a financing buy-in amount of 75.04 million yuan and a financing repayment of 78.03 million yuan, resulting in a net financing buy of -2.99 million yuan [1] - The total financing and securities balance for Huakang Clean reached 152 million yuan, accounting for 3.30% of the circulating market value, which is above the 90th percentile level over the past year, indicating a high financing level [1] - In terms of securities lending, Huakang Clean repaid 100 shares on December 24, with no shares sold, and a remaining securities lending balance of 6,900 shares valued at 295,200 yuan, also above the 90th percentile level over the past year [1] Business Performance - As of December 19, Huakang Clean had 10,700 shareholders, an increase of 3.08% from the previous period, while the average circulating shares per person decreased by 2.99% to 6,802 shares [2] - For the period from January to September 2025, Huakang Clean reported a revenue of 1.431 billion yuan, representing a year-on-year growth of 32.59%, and a net profit attributable to shareholders of 61.16 million yuan, which is a significant increase of 211.46% year-on-year [2] Dividend and Shareholding - Since its A-share listing, Huakang Clean has distributed a total of 40.02 million yuan in dividends, with 29.46 million yuan distributed over the past three years [3] - As of September 30, 2025, new institutional shareholders include Fortune Optimized Enhanced Bond A/B (100035) as the sixth largest shareholder with 1.8 million shares, and Fortune Jiuli Steady Allocation Mixed A (003877) as the ninth largest shareholder with 497,800 shares [3]

Core Viewpoint - Huakang Clean achieved significant revenue growth and profitability in the first nine months of 2025, indicating strong business performance in the medical purification sector [2]. Group 1: Financial Performance - For the period from January to September 2025, Huakang Clean reported operating revenue of 1.431 billion yuan, representing a year-on-year increase of 32.59% [2]. - The net profit attributable to the parent company reached 61.1567 million yuan, showing a substantial year-on-year growth of 211.46% [2]. Group 2: Shareholder and Market Activity - As of October 31, 2025, the number of Huakang Clean's shareholders increased to 10,600, up by 2.43% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 2.37% to 6,845 shares [2]. - On November 6, 2025, Huakang Clean's stock price rose by 0.40%, with a trading volume of 55.2064 million yuan [1]. Group 3: Financing and Margin Trading - On November 6, 2025, Huakang Clean had a financing buy-in amount of 6.5431 million yuan, while the financing repayment was 9.0856 million yuan, resulting in a net financing buy of -2.5425 million yuan [1]. - The total margin trading balance for Huakang Clean reached 98.7520 million yuan, accounting for 3.05% of its market capitalization, which is above the 90th percentile of the past year [1]. - There were no shares sold or repaid in the securities lending market on November 6, 2025, with the securities lending balance also at zero, indicating a high level of inactivity in this area [1]. Group 4: Dividend Distribution - Huakang Clean has distributed a total of 40.0214 million yuan in dividends since its A-share listing, with 29.4614 million yuan distributed over the past three years [3]. Group 5: Institutional Holdings - As of September 30, 2025, new institutional shareholders include Fortune Optimized Enhanced Bond A/B and Fortune Jiuli Steady Configuration Mixed A, which are now among the top ten circulating shareholders [3].

Core Viewpoint - Huakang Clean experienced a stock price decline of 2.16% on November 4, with a current price of 29.96 CNY per share and a market capitalization of 3.229 billion CNY [1] Financial Performance - For the period from January to September 2025, Huakang Clean achieved a revenue of 1.431 billion CNY, representing a year-on-year growth of 32.59% [2] - The net profit attributable to the parent company was 61.1567 million CNY, showing a significant year-on-year increase of 211.46% [2] Shareholder Information - As of October 20, 2025, the number of Huakang Clean's shareholders decreased by 1.61% to 10,400, while the average circulating shares per person increased by 1.64% to 7,011 shares [2] - The company has cumulatively distributed dividends of 40.0214 million CNY since its A-share listing, with 29.4614 million CNY distributed over the past three years [3] Stock Market Activity - Huakang Clean's stock has seen a year-to-date increase of 48.60%, but has declined by 3.48% over the last five trading days and 10.73% over the last 20 days [1] - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent appearance on July 31 [1] Business Overview - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean includes 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1] - The company operates within the pharmaceutical and biological industry, specifically in the medical device sector, and is involved in concepts such as medical waste treatment, assisted reproduction, medical devices, smart healthcare, and artificial intelligence [1]

Group 1 - The core viewpoint of the news is that Huakang Clean experienced a decline in stock price, dropping by 5.09% to 31.15 CNY per share, with a trading volume of 160 million CNY and a turnover rate of 6.99%, resulting in a total market capitalization of 3.357 billion CNY [1] - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean includes: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1] Group 2 - Among the top ten circulating shareholders of Huakang Clean, a fund under China Merchants Fund, specifically the China Merchants Quantitative Selected Stock A (001917), has newly entered the list in the third quarter, holding 470,000 shares, which accounts for 0.65% of the circulating shares [2] - The estimated floating loss for the fund today is approximately 784,800 CNY [2] - The China Merchants Quantitative Selected Stock A fund, established on March 15, 2016, has a latest scale of 3.663 billion CNY, with a year-to-date return of 43.95%, ranking 1030 out of 4218 in its category, and a one-year return of 48.62%, ranking 670 out of 3878 [2]

Group 1 - The core point of the news is that Huakang Clean experienced a decline of 5.42% in its stock price, reaching 33.70 CNY per share, with a trading volume of 53.69 million CNY and a turnover rate of 2.15%, resulting in a total market capitalization of 3.63 billion CNY [1] - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, is based in Wuhan, Hubei Province, and specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean includes: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other supplementary services [1] Group 2 - Among the top ten circulating shareholders of Huakang Clean, a fund under China Merchants Fund, specifically the China Merchants Quantitative Selected Stock A (001917), has newly entered the list in the third quarter, holding 470,000 shares, which accounts for 0.65% of the circulating shares [2] - The China Merchants Quantitative Selected Stock A fund, established on March 15, 2016, has a latest scale of 2.765 billion CNY, with a year-to-date return of 42.35% and a one-year return of 49.25%, ranking 1008 out of 4218 and 673 out of 3876 respectively [2] - The fund manager, Wang Ping, has a cumulative tenure of 15 years and 132 days, with the fund's total asset scale at 16.687 billion CNY, achieving a best return of 282.09% and a worst return of -70.61% during his tenure [2]

Core Viewpoint - Huakang Clean experienced a stock price decline of 2.01% on October 22, with a current price of 34.04 CNY per share and a total market capitalization of 3.668 billion CNY [1] Group 1: Stock Performance - Year-to-date, Huakang Clean's stock price has increased by 68.84%, with a recent decline of 1.36% over the last five trading days [1] - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on July 31 [1] Group 2: Financial Performance - For the first half of 2025, Huakang Clean reported a revenue of 833 million CNY, representing a year-on-year growth of 50.73%, and a net profit of 18.683 million CNY, up 273.48% year-on-year [2] - Cumulative cash dividends since the company's A-share listing amount to 40.0214 million CNY, with 29.4614 million CNY distributed over the past three years [3] Group 3: Shareholder Information - As of October 10, 2023, Huakang Clean had 10,500 shareholders, a decrease of 1.58% from the previous period, with an average of 6,898 circulating shares per shareholder, an increase of 1.60% [2] - Notable new institutional shareholders include Anxin Medical Health Stock A, holding 652,800 shares, and Nuoan Multi-Strategy Mixed A, holding 429,900 shares [3] Group 4: Business Overview - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The company's revenue composition includes 85.24% from purification system integration, 8.53% from medical consumables, 3.74% from medical equipment sales, 1.88% from operation services, and 0.61% from other sources [1]

Core Viewpoint - The stock of Huakang Clean has experienced fluctuations, with a year-to-date increase of 65.57% but a recent decline in the last five trading days by 2.40% [1] Financial Performance - For the first half of 2025, Huakang Clean achieved a revenue of 835 million yuan, representing a year-on-year growth of 50.73%, and a net profit attributable to shareholders of 18.68 million yuan, up 273.48% year-on-year [2] - The company has distributed a total of 40.02 million yuan in dividends since its A-share listing, with 29.46 million yuan distributed over the past three years [3] Stock Market Activity - As of October 20, Huakang Clean's stock price was 33.38 yuan per share, with a market capitalization of 3.597 billion yuan [1] - The stock has seen significant trading activity, with a turnover of 92.99 million yuan and a turnover rate of 3.77% on the same day [1] - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on July 31 [1] Shareholder Information - As of October 10, the number of shareholders for Huakang Clean was 10,500, a decrease of 1.58% from the previous period, while the average number of circulating shares per person increased by 1.60% to 6,898 shares [2] - Notable new institutional shareholders include Anxin Medical Health Stock A and Nuoan Multi-Strategy Mixed A, holding 652,800 shares and 429,900 shares respectively [3] Business Overview - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of the company includes 85.24% from purification system integration, 8.53% from medical consumables, 3.74% from medical equipment sales, 1.88% from operation services, and 0.61% from other sources [1]

Core Insights - Huakang Clean's stock price increased by 5.3% to 34.96 CNY per share, with a trading volume of 95.89 million CNY and a turnover rate of 3.91%, resulting in a total market capitalization of 3.768 billion CNY [1] Company Overview - Wuhan Huakang Century Clean Technology Co., Ltd. is located in the East Lake New Technology Development Zone, Wuhan, Hubei Province, and was established on November 12, 2008, with its listing date on January 28, 2022 [1] - The company's main business involves the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - Revenue composition: Purification system integration accounts for 85.24%, medical consumables sales 8.53%, medical equipment sales 3.74%, operation and maintenance services 1.88%, and other supplementary services 0.61% [1] Shareholder Insights - Anxin Fund has a presence among Huakang Clean's top ten circulating shareholders, with Anxin Medical Health Stock A (010709) newly entering the top ten in the second quarter, holding 652,800 shares, which is 1.28% of the circulating shares [2] - The estimated floating profit for Anxin Medical Health Stock A today is approximately 1.1489 million CNY [2] - Anxin Medical Health Stock A was established on January 12, 2021, with a latest scale of 442 million CNY, achieving a year-to-date return of 64.37%, ranking 201 out of 4220 in its category [2] Fund Management - The fund manager of Anxin Medical Health Stock A is Chi Chenshen, who has been in the position for 4 years and 276 days, managing a total fund size of 946 million CNY [3] - During his tenure, the best fund return was 56.95%, while the worst return was 53.28% [3]